Feed NRSNW
NR
NeuroSense Therapeutics Ltd.
NRSNW · NASDAQ
$0.06 -79.97% (-$0.24)
1M -51.92%
Market Cap $1.5M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$154.13
256355.9% upside
Preț actual
$0.06
Subevaluat Valoare justă Supraevaluat
Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 1,651.25%
ROA 0.00%
Debt
50 /100
Moderate Net debt/EBITDA 0.08x
Current ratio 0.71x
Int. coverage -97.39x
Stability
53 /100
Moderate Profitable years 0
Beta 1.56x
EPS volatility 7.33%
Întreabă StockBot despre NRSNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Alon Ben-Noon
Employees
16
Headquarters
Herzliya
Evenimente viitoare
02 SEPT.
Earnings
Upcoming earnings report